Cocrystal Pharma Stock Probability of Future Stock Price Finishing Over 26.87
| COCP Stock | USD 1.64 0.03 1.80% |
Cocrystal |
Cocrystal Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cocrystal Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cocrystal Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Cocrystal Pharma had very high historical volatility over the last 90 days | |
| Cocrystal Pharma may become a speculative penny stock | |
| Cocrystal Pharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (17.98 M) with loss before overhead, payroll, taxes, and interest of (14.77 M). | |
| Cocrystal Pharma currently holds about 51.03 M in cash with (14.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.28, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Cocrystal Pharma has a frail financial position based on the latest SEC disclosures | |
| Roughly 32.0% of the company shares are held by company insiders |
Cocrystal Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cocrystal Stock often depends not only on the future outlook of the current and potential Cocrystal Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cocrystal Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 9.7 M | |
| Cash And Short Term Investments | 26.4 M |
Cocrystal Pharma Technical Analysis
Cocrystal Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Cocrystal Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cocrystal Pharma. In general, you should focus on analyzing Cocrystal Stock price patterns and their correlations with different microeconomic environments and drivers.
Cocrystal Pharma Predictive Forecast Models
Cocrystal Pharma's time-series forecasting models is one of many Cocrystal Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Cocrystal Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Cocrystal Pharma
Checking the ongoing alerts about Cocrystal Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Cocrystal Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Cocrystal Pharma had very high historical volatility over the last 90 days | |
| Cocrystal Pharma may become a speculative penny stock | |
| Cocrystal Pharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (17.98 M) with loss before overhead, payroll, taxes, and interest of (14.77 M). | |
| Cocrystal Pharma currently holds about 51.03 M in cash with (14.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.28, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Cocrystal Pharma has a frail financial position based on the latest SEC disclosures | |
| Roughly 32.0% of the company shares are held by company insiders |
Additional Tools for Cocrystal Stock Analysis
When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.